Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,576.97
(
-0.04%
)
US TECH 100
29,501.60
(
-0.10%
)
Dow Jones
50,891.75
(
-0.28%
)
Brent Oil
96.41
(
5.52%
)
Bitcoin
71,533.81
(
-2.75%
)
News Focus
News Focus
Post# of 57994
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

neuroinv

Send PM Follow Ignore
Followers 32
Posts 2552
Boards Moderated 0
Alias Born 07/16/2006

neuroinv

Re: tregaron post# 21445

Monday, 10/20/2008 3:47:13 PM

Monday, October 20, 2008 3:47:13 PM

Post# of 57994
Near zero.

Re: Prialt/ziconotide/SNX-111. That's been available for four years. It's been a disappointment, mainly because it's very easy to get serious cognitive side effects. No RD risk that I know of, but it's never become anything near the competitive factor that it was expected to be back in its Neurex 'snail juice' days.

NeuroInvestment
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today